Andrew Robert Goodey

Title: Innovations by Andrew Robert Goodey: A Pioneer in High Purity Albumin Production

Introduction

Andrew Robert Goodey, based in Mapperley Park, GB, is a prolific inventor with a remarkable portfolio of seven patents. His work primarily focuses on the production and purification of albumin, a vital protein used in various medical and biotechnological applications. Goodey's innovative processes have significantly contributed to advancements in biotechnology, particularly in improving the quality of albumin production.

Latest Patents

Goodey’s latest patents revolve around processes for achieving high purity albumin production. One notable process involves preparing albumin from a yeast culture medium with extremely low levels of contaminants such as colorants, metal ions, human proteins, and viruses. This innovative method ensures that the albumin is non-glycated, relatively high in free thiol, and maintains an intact C-terminus. The steps consist of separating the yeast from the culture medium to yield a pure albumin solution, which undergoes several chromatography techniques including positive mode cation exchange and anion exchange, leading to a concentrated and formulated product with sodium octanoate and sodium chloride.

Furthermore, another patent details a similar high purity albumin production process that utilizes transformed yeast and incorporates various chromatography techniques, ultrafiltration, and gel permeation chromatography. This comprehensive approach simplifies the purification process and enhances the quality of the final product.

Career Highlights

Goodey has had an impressive career, working with reputable companies such as Delta Biotechnology Limited and Novozymes Delta, Limited. His role at these organizations has allowed him to pioneer new techniques and contribute to the field of biotechnology effectively. His innovative efforts not only focus on process enhancement but also emphasize the importance of purity and quality in biotechnology applications.

Collaborations

Throughout his career, Goodey has collaborated with esteemed colleagues including Darrell Sleep and Stephen Berezenko. Their joint efforts have led to significant advancements in the techniques used for albumin purification, showcasing a team-oriented approach to innovation in the field.

Conclusion

Andrew Robert Goodey stands out as a leading figure in the realm of biotechnology innovation. His dedication to developing high purity albumin production processes exemplifies his commitment to enhancing the quality and efficiency of bioproducts. With a robust patent portfolio and a collaborative spirit, Goodey continues to make impactful contributions to science and technology.